Cross Country Healthcare, Inc.
NASDAQ:CCRNMedical - Care Facilities
+$0.01 today
- Market cap
- $428.06M
- Beta
- 0.45
- P/E (TTM)
- -4.2
- EPS (TTM)
- -$3.13
Volume 1.78M
Average 0.64M
CCRN Net Margin
Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.
Cross Country Healthcare, Inc.NASDAQ: CCRN
Net Margin · Q1 FY2026 · quarter ended Mar 2026
Net margin narrows to -1.8%
Net margin was -1.8% in Q1 FY2026, down 1.6 pp from a year earlier. On a trailing-twelve-month basis it was -9.8%, down 8.4 pp year over year. Over 3 fiscal years it narrowed by 15.6 pp.
Context
- Net margin widened in 0 of the last 3 fiscal years.
- FY2025 was the lowest level in the 4 fiscal years shown.
What to watch
Whether net margin reaches the consensus estimate from 6 analysts of 0.3% for the fiscal year ending Dec 2026, up from -9.0% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -1.8%+33.3 pp QoQ
- Last fiscal yearDec 2025
- -9.0%-7.9 pp YoY
- LTMMar 2026
- -9.8%-8.4 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -1.6 pp | +2.6 pp | +4.2 pp |
| 1 year | -7.9 pp | +9.3 pp | +17.2 pp |
| 3 years | -15.6 pp | +9.9 pp | +25.5 pp |
| 5 years | +11.8 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -9.0%
- Year-over-year change
- -7.9pp
| Period | Period end | Net Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -9.0% | -7.9pp |
| FY2024 | 2024-12-31 | -1.1% | -4.7pp |
| FY2023 | 2023-12-31 | 3.6% | -3.0pp |
| FY2022 | 2022-12-31 | 6.6% | -1.2pp |
| FY2021 | 2021-12-31 | 7.9% | — |
Net Margin vs competitors
How CCRN compares with its peers on the latest reported figures
- CCRN's LTM Mar 2026 net margin of -9.8% is the 6th highest of the 9 companies compared; the peer median is -7.2%.
- Its year-over-year change of -8.4 pp is the 8th highest of 9, against a peer median of +0.3 pp.
- Over three fiscal years its change of -15.6 pp compares with a peer median of +2.4 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
MCTACharming Medical Limited Class A Ordinary Shares | FY2024 | 19.3% | +6.3 pp | — |
| LTM Mar 2026 | 6.4% | +22.7 pp | +23.0 pp | |
AUNAAuna S.A. | LTM Mar 2026 | 1.5% | -2.1 pp | +5.7 pp |
| LTM Mar 2026 | -6.4% | -2.4 pp | -2.4 pp | |
| LTM Mar 2026 | -8.0% | +8.0 pp | -12.1 pp | |
| LTM Mar 2026 | -9.8% | -8.4 pp | -15.6 pp | |
| LTM Mar 2026 | -16.3% | +2.8 pp | -17.8 pp | |
| LTM Mar 2026 | -24.2% | -11.5 pp | +4.2 pp | |
| LTM Mar 2026 | -29.4% | -4.3 pp | +2.4 pp | |
| Peer median (excluding CCRN) | -7.2% | +0.3 pp | +2.4 pp | |
Competitors are the stored peer set for CCRN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.68B | 2.8B | 2.02B | 1.34B | 1.05B |
| Cost of Revenue | 1.3B | 2.18B | 1.57B | 1.07B | 857.52M |
| Gross Profit | 375M | 624.46M | 450.41M | 274.25M | 196.78M |
| Gross Margin | 22.4% | 22.3% | 22.3% | 20.4% | 18.7% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 220.04M | 324.21M | 314.95M | 254.81M | 200.68M |
| Operating Expenses | 235.7M | 354.58M | 337.7M | 291.12M | 200.24M |
| Depreciation & Amortization | 9.45M | 12.58M | 18.35M | 17.5M | 16.79M |
| EBITDA | 154.56M | 280.06M | 129.34M | 16.77M | (64.5M) |
| EBITDA Margin | 9.2% | 10.0% | 6.4% | 1.2% | -6.1% |
| Operating Income | 139.3M | 269.88M | 112.71M | (16.87M) | (3.46M) |
| Operating Margin | 8.3% | 9.6% | 5.6% | -1.3% | -0.3% |
| Interest Income | 0 | 10K | 0 | 2.05M | 3.13M |
| Interest Expense | 6.87M | 14.39M | 8.09M | 2.19M | 2.22M |
| Other Income / Expenses | (6.1M) | (16.78M) | (9.82M) | 467K | (80.05M) |
| Income Before Tax | 133.21M | 253.1M | 102.89M | (16.4M) | (83.51M) |
| Pre-Tax Margin | 7.9% | 9.0% | 5.1% | -1.2% | -7.9% |
| Income Tax Expense | 1.21M | 67.12M | 30.26M | (1.84M) | 11.34M |
| Net Income | 132M | 185.98M | 72.63M | (14.56M) | (94.85M) |
| Net Margin | 7.9% | 6.6% | 3.6% | -1.1% | -9.0% |
| EPS (Basic) | 3.60 | 5.09 | 2.07 | (0.44) | (2.93) |
| EPS (Diluted) | 3.53 | 5.02 | 2.05 | (0.44) | (2.93) |
| Weighted Avg Shares | 36.69M | 37.01M | 35.16M | 33.38M | 32.41M |
| Weighted Avg Shares (Diluted) | 37.39M | 37.54M | 35.48M | 33.38M | 32.41M |
Cross Country Healthcare, Inc.
NASDAQ:CCRN
Intrinsic Alpha fair value
Locked
Current Price
$13.25
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.